Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Background. The prognostic significance of a second programmed ventricular stimulation (PVS) at electrophysiology study (EPS), when the first PVS is negative for inducible ventricular tachycardia (VT) ...

SAN DIEGO, February 17, 2026--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP ...

Early Intensive GDMT Regimen May Boost Recovery in HFrEF Early and intensive guideline-directed medical therapy shows the recovery of heart function within 3 months among patients newly diagnosed with ...

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...